• Lutte contre les cancers

  • Observation

  • Système nerveux central

Survival from tumours of the central nervous system in Danish children: Is survival related to family circumstances?

A partir des données des registres danois des cancers portant sur 1 261 enfants nés entre 1973 et 2006 et atteints d'une tumeur du système nerveux central avant l'âge de 20 ans, cette étude analyse les caractéristiques familiales associées à la survie (âge des parents, nombre de frères et soeurs, vie citadine,...; durée de suivi : 10 ans)

Little is known about social inequalities in childhood cancer survival. We investigated the impact of family circumstances on survival from paediatric central nervous system (CNS) tumours in a nationwide, register-based cohort of Danish children. All children born between 1973 and 2006 and diagnosed with a CNS tumour before the age of 20 years (N = 1,261) were followed until 10 years from diagnosis. Using Cox proportional hazards models, the impact of various family characteristics on overall survival was estimated. Hazard ratios (HRs) for all CNS tumours combined did not show strong associations between survival and any family characteristic. Analyses by CNS tumour subtypes showed reduced survival for children with glioma when living outside of Copenhagen (HR 1.55; CI 1.03; 2.35). For embryonal CNS tumours, the number of full siblings was associated with worse survival (HR for having 3+ siblings 3.60; CI 1.52; 8.53) and a trend of better survival was observed for children with parents of younger age at child's diagnosis and poorer survival of children with parents of older age. Despite free and uniform access to health care services, some family circumstances appear to affect survival from specific CNS tumour types in Danish children. Further research is warranted to gain a more comprehensive understanding of the impact of family factors on childhood cancer survival in other populations and to elaborate underlying mechanisms and pathways of those survival inequalities observed.

International Journal of Cancer 2017

Voir le bulletin